Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Kidney International
|
November 22, 2024
Has APOL1 kidney disease treatment been hiding in plain sight?
Opeyemi A Olabisi
Seminars in Nephrology
|
November 8, 2017
APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?
Opeyemi A Olabisi, John F Heneghan
Kidney International
|
June 22, 2021
APOL1-associated kidney disease in northern Nigerians with treated HIV infection
Opeyemi A Olabisi, Barry I Freedman
Methods in Molecular Biology (Clifton, N.J.)
|
August 27, 2011
Assay for protein modification by poly-ADP-ribose in vitro
Opeyemi A Olabisi, Chi-Wing Chow
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 20, 2004
Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies
Patricia A Broderick, Opeyemi A Olabisi, David N Rahni, et al.
Journal of the American Society of Nephrology : JASN
|
July 18, 2020
Kidney Disease-Associated <i>APOL1</i> Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function
Somenath Datta, Rama Kataria, Jia-Yue Zhang, et al.
Kidney International Reports
|
September 18, 2024
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE)
Opeyemi A Olabisi, Nadine J Barrett, Anika Lucas, et al.
JCI Insight
|
April 26, 2022
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids
Sarah E Nystrom, Guojie Li, Somenath Datta, et al.
Kidney International Reports
|
September 18, 2024
APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination
Sarah E Nystrom, Karen L Soldano, Micki Rockett, et al.
Journal of the American Society of Nephrology : JASN
|
March 3, 2026
Hybrid Community-EHR Approaches to APOL1 Kidney Disease Screening and Clinical Trials among Black Individuals
Nadine Barrett, Joab O Odera, Kenisha Bethea, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Kidney International
|
November 22, 2024
Has APOL1 kidney disease treatment been hiding in plain sight?
Opeyemi A Olabisi
Seminars in Nephrology
|
November 8, 2017
APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?
Opeyemi A Olabisi, John F Heneghan
Kidney International
|
June 22, 2021
APOL1-associated kidney disease in northern Nigerians with treated HIV infection
Opeyemi A Olabisi, Barry I Freedman
Methods in Molecular Biology (Clifton, N.J.)
|
August 27, 2011
Assay for protein modification by poly-ADP-ribose in vitro
Opeyemi A Olabisi, Chi-Wing Chow
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 20, 2004
Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies
Patricia A Broderick, Opeyemi A Olabisi, David N Rahni, et al.
Journal of the American Society of Nephrology : JASN
|
July 18, 2020
Kidney Disease-Associated <i>APOL1</i> Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function
Somenath Datta, Rama Kataria, Jia-Yue Zhang, et al.
Kidney International Reports
|
September 18, 2024
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE)
Opeyemi A Olabisi, Nadine J Barrett, Anika Lucas, et al.
JCI Insight
|
April 26, 2022
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids
Sarah E Nystrom, Guojie Li, Somenath Datta, et al.
Kidney International Reports
|
September 18, 2024
APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination
Sarah E Nystrom, Karen L Soldano, Micki Rockett, et al.
Journal of the American Society of Nephrology : JASN
|
March 3, 2026
Hybrid Community-EHR Approaches to APOL1 Kidney Disease Screening and Clinical Trials among Black Individuals
Nadine Barrett, Joab O Odera, Kenisha Bethea, et al.
Page
of 2